Details

Autor(en) / Beteiligte

• Chang, Shao-Yu
• Kambe, Naotomo
• Fan, Wen-Lang
• Huang, Jing-Long
• Lee, Wen-I
• Wu, Chao-Yi

Titel

Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome

Ist Teil von

• Pediatric rheumatology online journal, 2022-10, Vol.20 (1), p.86-86, Article 86

Ort / Verlag

London: BioMed Central Ltd

Erscheinungsjahr

2022

Quelle

SpringerLink Journals - AutoHoldings

Beschreibungen/Notizen

• Background Blau syndrome (BS) is a rare autoinflammatory disorder with NOD2 gain-of-function mutation and characterized by autoactivation of the NFκB pathway. Classically considered a disease of high penetrance, reports on NOD2 mutations underlining BS with incomplete penetrance is limited. Case presentation The proband is a 9-year-old girl presented with brownish annular infiltrative plaques and symmetric boggy polyarthritis over bilateral wrists and ankles. Her skin biopsy revealed noncaseating granulomas inflammation with multinucleated giant cells. A novel C483W NOD2 mutation was identify in the proband and her asymptomatic father. Functional examinations including autoactivation of the NFκB pathway demonstrated by in vitro HEK293T NOD2 overexpression test as well as intracellular staining of phosphorylated-NFκB in patient's CD11b.sup.+ cells were consistent with BS. Conclusions We reported a novel C483W NOD2 mutation underlining BS with incomplete penetrance. Moreover, a phosphorylated-NFκB intracellular staining assay of CD11b.sup.+ was proposed to assist functional evaluation of NFκB autoactivation in patient with BS. Keywords: Blau syndrome, NOD2, Incomplete penetrance, NFκB